CORT financials
Corcept Therapeutics (CORT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CORT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $761.41M | $748.43M | $44.80M | $99.65M | 0.82 |
| 2024 | $675.04M | $664.16M | $136.95M | $139.73M | 1.23 |
| 2023 | $482.38M | $475.89M | $107.28M | $106.14M | 0.94 |
| 2022 | $401.86M | $396.47M | $112.63M | $101.42M | 0.87 |
| 2021 | $365.98M | $360.70M | $124.48M | $112.51M | 0.89 |
| 2020 | $353.87M | $348.29M | $128.20M | $106.01M | 0.85 |
- CORT revenue was $761.41M in fiscal 2025, net income $99.65M.
Updated 2026-11-03 00:45 UTC